PubMed Health⌕ Search

PubMed · 10498995

Perceived area and the luminosity threshold.

Abstract

Observers made forced-choice opaque/luminous responses to targets of varying luminance and varying size presented (1) on the wall of a laboratory, (2) as a disk within an annulus, and (3) embedded within a Mondrian array presented within a vision tunnel. Lightness matches were also made for nearby opaque surfaces. The results show that the threshold luminance value at which a target begins to appear self-luminous increases with its size, defined as perceived size, not retinal size. More generally, the larger the target, the more an increase in its luminance induces grayness/blackness into the surround and the less it induces luminosity into the target, and vice versa. Corresponding to this luminosity/grayness tradeoff, there appears to be an invariant: Across a wide variety of conditions, a target begins to appear luminous when its luminance is about 1.7 times that of a surface that would appear white in the same illumination. These results show that the luminosity threshold behaves like a surface lightness value--the maximum lightness value, in fact--and is subject to the same laws of anchoring (such as the area rule proposed by Li & Gilchrist, 1999) as surface lightness.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F Bonato, A L Gilchrist. 1999. Perceived area and the luminosity threshold.. https://doi.org/10.3758/bf03206897

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗